Inhibikase Therapeutics

Pharmaceutical Manufacturing • Wilmington, Delaware, United States • 21-50 Employees

Company overview

Headquarters	1000 N West St, Suite 1200, Wilmington, Delaware 19801, US
Phone number	+16179360184
Website	inhibikase.com
NAICS	3254
SIC	283
Employees	21-50
Socials

Key Contacts at Inhibikase Therapeutics

Leona Blustein

Senior Director, Medical Affairs

Vincent Aurentz

Member Board Of Directors

Alisha Lundholm

Senior Director, Corporate Controller

Emaryn Mancino

Director Clinical Operations

Evette Brooks

Senior Director, Field Medical

Mark Iwicki

Chief Executive Officer

Roy Freeman

Director

Inhibikase Therapeutics Email Formats

Inhibikase Therapeutics uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@inhibikase.com), used 38.1% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@inhibikase.com	38.1%
{first initial}{last name}	jdoe@inhibikase.com	33.3%
{last name}{last name}	doedoe@inhibikase.com	19%
{second initial}{last name}	odoe@inhibikase.com	9.5%

About Inhibikase Therapeutics

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of pulmonary arterial hypertension (PAH).Inhibikase is headquartered in Wilmington, DE with additional offices in Boston, Massachusetts.

Inhibikase Therapeutics revenue & valuation

Annual revenue	$260,501
Revenue per employee	$11,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$833,603
Total funding	$124,000,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

C-Suite

Entry

Employees by Department

Inhibikase Therapeutics has 15 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore Inhibikase Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-02-25	14	$10,000,000
2024-06-20	14	$4,000,000
2024-11-09	14	$110,000,000

Funding Insights

$124,000,000

Total funding amount

$110,000,000

Most recent funding amount

Number of funding rounds

Inhibikase Therapeutics Tech Stack

Discover the technologies and tools that power Inhibikase Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Browser-Update.org

JavaScript libraries

PWA

Miscellaneous

Microsoft 365

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Quotemedia

Analytics

HSTS

Security

Google Analytics

Analytics

YouTube

Video players

Bootstrap

UI frameworks

hCaptcha

Security

Amazon S3

CDN

Frequently asked questions

Inhibikase Therapeutics is located in Wilmington, Delaware, US.

You can reach Inhibikase Therapeutics at +16179360184.

Inhibikase Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Inhibikase Therapeutics has raised a total of $124,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.